Netherlands Cancer Insitute
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1913-10-10
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.nki.nl
Basket Study for Oligo-metastatic Breast Cancer
- First Posted Date
- 2023-08-08
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- The Netherlands Cancer Institute
- Target Recruit Count
- 72
- Registration Number
- NCT05982678
- Locations
- 🇳🇱
Antoni van Leeuwenhoek, Amsterdam, Netherlands
Subtherapeutic Dose of Piracetam as a Therapy Adherence Marker
- First Posted Date
- 2023-06-26
- Last Posted Date
- 2023-06-26
- Lead Sponsor
- The Netherlands Cancer Institute
- Target Recruit Count
- 10
- Registration Number
- NCT05918341
Primary Chemoradiation VS. Neoadjuvant Chemotherapy Followed By Surgery As Treatment Strategy For LAVC
Phase 2
Recruiting
- Conditions
- Squamous Cell Carcinoma of the VulvaLocally Advanced Vulvar Carcinoma
- Interventions
- Combination Product: Chemoradiation
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2024-04-15
- Lead Sponsor
- The Netherlands Cancer Institute
- Target Recruit Count
- 98
- Registration Number
- NCT05905315
- Locations
- 🇳🇱
NKI-AVL, AMsterdam, Netherlands
🇳🇱LUMC, Leiden, Netherlands
Navigated Abdominal Lymph Node Dissections
Not Applicable
Completed
- Conditions
- Image-guide SurgeryLymph Node Metastasis
- First Posted Date
- 2023-05-19
- Last Posted Date
- 2023-05-19
- Lead Sponsor
- The Netherlands Cancer Institute
- Target Recruit Count
- 69
- Registration Number
- NCT05867095
- Locations
- 🇳🇱
Netherlands Cancer Institute, Amsterdam, North Holland, Netherlands
'Cancer Patients Better Life Experience'
Not Applicable
Recruiting
- Conditions
- Melanoma
- First Posted Date
- 2023-04-25
- Last Posted Date
- 2023-07-06
- Lead Sponsor
- The Netherlands Cancer Institute
- Target Recruit Count
- 36
- Registration Number
- NCT05827289
- Locations
- 🇳🇱
Netherlands Cancer Institute, Amsterdam, North Holland, Netherlands
Organ Preservation in Rectal Cancer: Contact X-ray Brachytherapy vs Extending the Waiting Interval and Local Excision
Not Applicable
Recruiting
- Conditions
- Locally Advanced Rectal CarcinomaOrgan PreservationQuality of LifeRectal Cancer
- First Posted Date
- 2023-03-17
- Last Posted Date
- 2023-03-17
- Lead Sponsor
- The Netherlands Cancer Institute
- Target Recruit Count
- 168
- Registration Number
- NCT05772923
- Locations
- 🇳🇱
Medical Center Leeuwarden, Leeuwarden, Friesland, Netherlands
🇳🇱Radbouw University Medical Centre, Nijmegen, Gelderland, Netherlands
🇳🇱Catharina Hospital, Eindhoven, Noord-Brabant, Netherlands
The Food-effect on Alectinib Pharmacokinetics
Not Applicable
Completed
- Conditions
- NSCLC
- First Posted Date
- 2023-02-02
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- The Netherlands Cancer Institute
- Target Recruit Count
- 10
- Registration Number
- NCT05710133
- Locations
- 🇳🇱
Netherlands Cancer Institute, Amsterdam, North Holland, Netherlands
Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer
Not Applicable
Recruiting
- Conditions
- Prostate Cancer
- First Posted Date
- 2023-01-31
- Last Posted Date
- 2024-06-07
- Lead Sponsor
- The Netherlands Cancer Institute
- Target Recruit Count
- 484
- Registration Number
- NCT05705921
- Locations
- 🇳🇱
Netherlands Cancer Institute, Amsterdam, Netherlands
Phase I/II study with galunisertib combined with capecitabine in patients with advanced chemotherapy resistant colorectal cancer with peritoneal metastases
Phase 1/2
Recruiting
- Conditions
- colorectal cancer
- First Posted Date
- 2025-01-23
- Last Posted Date
- 2025-01-23
- Target Recruit Count
- 31
- Registration Number
- 2024-518980-37-00
- Locations
- 🇳🇱
Amsterdam UMC Stichting, Amsterdam, Netherlands
🇳🇱Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam, Netherlands
Effect of a Bundle of Non-pharmacological Interventions on the Stress Response to Surgery
Not yet recruiting
- Conditions
- Surgical InjuryStress, PhysiologicalPain, PostoperativeStress, Psychological
- First Posted Date
- 2022-12-06
- Last Posted Date
- 2023-03-20
- Lead Sponsor
- The Netherlands Cancer Institute
- Target Recruit Count
- 90
- Registration Number
- NCT05638152